Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Go Omura

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cancers|November 21, 2020
Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 PatientsTakashi Matsuki, Isaku Okamoto, Chihiro Fushimi, et al.
Oral Oncology|April 19, 2026
Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trialTomoya Yokota, Naomi Kiyota, Takeshi Kodaira, et al.
Frontiers in Oncology|May 14, 2021
Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell CarcinomaTairo Kashihara, Satoshi Nakamura, Naoya Murakami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 2024
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland NeoplasmsAiri Sakyo, Eijitsu Ryo, Shogo Nishino, et al.
Asia-Pacific Journal of Clinical Oncology|September 8, 2025
Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With PembrolizumabTakashi Matsuki, Takuro Okada, Chihiro Fushimi, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
International Journal of Clinical Oncology|February 6, 2025
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysisHirotaka Shinomiya, Kazuto Matsuura, Rikiya Onimaru, et al.
Head & Neck|November 13, 2023
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective studyYosuke Ariizumi, Nobuhiro Hanai, Takahiro Asakage, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cancers|November 21, 2020
Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 PatientsTakashi Matsuki, Isaku Okamoto, Chihiro Fushimi, et al.
Oral Oncology|April 19, 2026
Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trialTomoya Yokota, Naomi Kiyota, Takeshi Kodaira, et al.
Frontiers in Oncology|May 14, 2021
Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell CarcinomaTairo Kashihara, Satoshi Nakamura, Naoya Murakami, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 1, 2024
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland NeoplasmsAiri Sakyo, Eijitsu Ryo, Shogo Nishino, et al.
Asia-Pacific Journal of Clinical Oncology|September 8, 2025
Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With PembrolizumabTakashi Matsuki, Takuro Okada, Chihiro Fushimi, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
International Journal of Clinical Oncology|February 6, 2025
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysisHirotaka Shinomiya, Kazuto Matsuura, Rikiya Onimaru, et al.
Head & Neck|November 13, 2023
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective studyYosuke Ariizumi, Nobuhiro Hanai, Takahiro Asakage, et al.
Pageof 7